avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis1 | mm10_v2_chr11_-_19018956_19018973 | 0.51 | 1.6e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_46404224 Show fit | 9.70 |
ENSMUST00000107764.2
|
hemogen |
|
chr4_-_41098174 Show fit | 9.54 |
ENSMUST00000055327.7
|
aquaporin 3 |
|
chr11_+_58918004 Show fit | 9.05 |
ENSMUST00000108818.3
ENSMUST00000020792.5 |
butyrophilin-like 10 |
|
chr11_-_69617879 Show fit | 7.43 |
ENSMUST00000005334.2
|
sex hormone binding globulin |
|
chr14_-_47411666 Show fit | 6.68 |
ENSMUST00000111778.3
|
discs, large (Drosophila) homolog-associated protein 5 |
|
chr4_-_87806296 Show fit | 6.30 |
ENSMUST00000126353.1
ENSMUST00000149357.1 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
|
chr9_+_7558429 Show fit | 5.98 |
ENSMUST00000018765.2
|
matrix metallopeptidase 8 |
|
chr4_-_87806276 Show fit | 5.78 |
ENSMUST00000148059.1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
|
chr6_+_34412334 Show fit | 5.47 |
ENSMUST00000007449.8
|
aldo-keto reductase family 1, member B7 |
|
chr7_+_78913436 Show fit | 4.69 |
ENSMUST00000121645.1
|
interferon-stimulated protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 12.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.2 | 9.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.8 | 9.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 8.6 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.4 | 8.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 6.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 5.7 | GO:0022412 | cellular process involved in reproduction in multicellular organism(GO:0022412) |
1.4 | 4.3 | GO:0071846 | actin filament debranching(GO:0071846) |
0.0 | 4.3 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 4.2 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 12.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 9.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 9.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 8.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.3 | 6.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 5.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 4.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 3.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 3.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 3.7 | GO:0016234 | inclusion body(GO:0016234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.2 | 9.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 8.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 7.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 6.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 6.3 | GO:0005496 | steroid binding(GO:0005496) |
0.6 | 5.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 4.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 4.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 3.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 8.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 7.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 6.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 6.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 4.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 9.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 6.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 6.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 2.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |